Bristol-Myers Squibb swallows Celgene for $74 billion

[anonymous]

Bristol-Myers Squibb acquires Celgene for $74 billion.

Celgene stock surges while BMY plunges. 2019 starts well for Celgene. More M&As are in the pipeline in the biopharma space.

 

[anonymous]

yes BMY does swallow, but this time I expect they will sodomize.

 

[anonymous]

yes BMY does swallow, but this time I expect they will sodomize.

Stop it, you are getting me hard.

 

[anonymous]

Let's just hope they give us the common courtesy for a reach around this time. Unlike Celgene. No manners whatsoever. I mean hell if you're not gonna use lube at least let the receiver manage the angle and pace lol.